Liraglutide, Next-Generation Antidiabetic Medication

By DrugDevelopmentTechnology.com Published at March 13, 2009 Views 306 Comments 1 Likes 1

Under development by Novo Nordisk, liraglutide is a member of a new class of antidiabetic medications called GLP-1 analogues. These mirror the effects of naturally produced glucagon-like peptide-1 (GLP-1), which includes glucose-dependent stimulation of insulin secretion, suppression of glucagon secretion, reduction of appetite and delay of food absorption.

Read the full article at www.drugdevelopment

1

Like

I like this I don't like this

Avera March 13, 2009 at 11:11 pm

0 Likes

I like this I don't like this Report as inappropriate

When someone posts about a new medicine being developed, I always read it. I can't wait until all the new ones are approved. They will be expensive but new ones like this have less side effects they are saying.